| abstract |
The present invention relates to pharmaceutical compositions that can specifically induce cell death in proliferating angiogenic endothelial cells and associated solid tumors and other angiogenesis-related diseases. More particularly, the invention relates to nucleotide constructs that are selectively active in angiogenic endothelial cells and encode highly toxic agents for expression in such cells (eg, diphtheria toxin). . [Selection diagram] None |